Alternatives to Dnsgvtissue

Leveraging the adaptive immune system to diagnose and treat disease.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Harnessing genetic data for digital insights in rare and germline disorders.

AI-powered platform for personalized cell therapy development and manufacturing.

Personalized care platform for actionable medication management and patient journey optimization.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.